Tag Archives: Mesabi Trust

2 Shale Plays and 1 Mining Ironman

By Doug Ehrman, The Motley Fool

Filed under:

The boom in U.S. energy resulting from the explosion in shale oil and gas is nothing short of remarkable. Not only has this new technology shifted America’s dependence on foreign energy sources, but it has also effectively kept inflation in check and given the Federal Reserve room to maneuver. While the role of the majors tends to get the most ink, there are two blossoming companies that will give you great upside exposure to the industry. The first, Halcon Resources , has asset plays in a variety of areas in the U.S., including the Bakken formation. The second, Heckmann , is a less direct play, as the company is in the business of helping companies manage the waste their mining operations create.

Not far from the bustle of North Dakota’s Bakken shale activity, the Mesabi Trust , near Babbitt, Minn., is quietly churning out iron ore and an 8.5% dividend yield. In addition to having solid trust characteristics, the company has solid analyst support. Let’s look at each of these companies and why they might deserve a slot in your portfolio.

Halcon Resources: This up-and-coming shale oil company’s Bakken asset accounts for 45% of proven reserves and 50% of the company’s pro forma production. As a part of its most recent earnings release, the company reported a 417% increase in proven reserves and a 128% increase in net daily production. As of Dec. 31, proven reserves stood at roughly 109 million oil equivalent barrels from both oil and natural gas holdings. In addition to its presence in the Bakken region, the company has significant resources in both the Woodbine/Eagle Ford and Uttica.

In the fourth-quarter earnings call, CEO Floyd Wilson talked about the positive outlook for the company, stating: “[O]ur focus is on developing our resource base and growing production reserves and cash flow. The balance sheet is healthy, and we are well positioned to execute our business plan.” The company is functioning in line with its own projections and gives investors solid exposure to shale gas and oil on a more pure-play basis. Given the growth nature of both the sector and this company, Halcon is a good bet.

Heckmann: This company operates in the service sector, but it represents one of the most critical elements of shale operations outside the actual drilling. Drilling, and, to an even greater extent, hydraulic fracturing require huge amounts of water. Estimates show that there are approximately 11,400 new wells drilled in the U.S. every year, each requiring a projected 6.1 million gallons of water to operate. That totals about 70 billion gallons of water per year. Heckmann is in the business of not only getting fresh water to these mines, but also in treating and processing the wastewater that each mine creates.

Environmental concerns have become a significant financial element of mining as regulations continue to get more stringent. Deploying capital in a company that profits from helping miners and drillers to meet these …read more
Source: FULL ARTICLE at DailyFinance

Here's What This $41 Billion Hedge Fund Company Has Been Buying

By Selena Maranjian, The Motley Fool

Filed under:

Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a bright light on smart stock picks.

Today, let’s look at the D. E. Shaw company, founded by David E. Shaw and with a reportable stock portfolio totaling $41 billion in value as of Dec. 31, 2012.

Shaw is known as a math wizard and a quantitative investing pioneer. His firm is reportedly extremely selective, hiring less than 1% of applicants — and Amazon.com CEO Jeff Bezos once made the cut.

Interesting developments
So what does D. E. Shaw’s latest quarterly 13F filing tell us? Here are a few interesting details:

The biggest new holdings are Kraft Foods Group and ADT. Other new holdings of interest include Spectrum Pharmaceuticals . Spectrum has been experiencing strong growth due to the success of its colorectal cancer drug Fusilev, but that was partly due to a supply shortage faced by generic competitors. With that issue going away, Spectrum recently trimmed its growth expectations, sending the heavily shorted stock down sharply. Still, it has more than a dozen other drugs in development in its pipeline, and has broadened its scope with the recent purchase of Allos Therapeutics, which is expected to help cut costs and also includes the lymphoma drug Folotyn. Spectrum also recently secured rights for the bladder-cancer drug apaziquone.

Among holdings in which D. E. Shaw increased its stake was Acadia Pharmaceuticals , which has tripled in value over the past year, on high hopes for its pimavanserin drug, which treats psychosis in patients with Parkinson’s disease and is nearing the phase 3 trial finish line. If the drug gains FDA approval, it will enjoy little competition and could be a big winner for Acadia. The company thinks the drug also might be effective against psychosis related to Alzheimer’s Disease and is conducting trials for that as well.

D. E. Shaw reduced its stake in lots of companies, including Mesabi Trust and Molycorp . With a recent hefty dividend yield of 8.2%, Mesabi Trust is a royalty trust collecting a cut of the proceeds from iron mined by a Cliffs Natural Resources subsidiary — and then paying them out to shareholders. Unlike many companies with fixed payouts, Mesabi’s fluctuate over time, along with the fortunes of the mines, and while royalty trusts often have expiration dates, Mesabi’s expiration isn’t happening anytime soon. A possible downside for the stock is a slowdown in demand for ore, particularly in China, which has been one of several issues for Cliffs.

Molycorp has been struggling in a tough environment and recently worried investors with a surprisingly large share offering and debt issuance. (Some worry about further capital needs, too, and don’t like its negative free cash flow.) Still, for those who can accept considerable risk and volatility, there’s a lot of promise in Molycorp, in part due to its acquisition of Neo Materials …read more
Source: FULL ARTICLE at DailyFinance